From: A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges
N° Pt. Ttt | Ht (%) | pCai t0’ | CiWB | cCai t5’ | cCai max | PTF | TF |
---|---|---|---|---|---|---|---|
A.1 | 40 | 1.14 | 2.4 | 0.40 | 0.42 | Y | N |
B.1 | 27 | 1.00 | 2.4 | 0.37 | 0.37 | Y | Y |
B.2 | 25 | 1.07 | 2.4 | 0.41 | 0.41 | Y | N |
B.3 | 26 | 0.83 | 2.4 | 0.40 | 0.47 | Y | Y |
C.1 | 27 | 1.27 | 3.0 | 0.39 | 0.39 | y | Y |